CSPC PHARMA (01093): The trustee purchased a total of 5,950,000 company shares under the 2026 stock award plan.
China Resources Pharmaceutical Group Limited (01093) announced that on June 25, 2026, the trustee purchased a total of 5.95 million shares of the company on the market in accordance with the terms and conditions of the 2026 stock incentive plan, and held the shares in trust for the benefit of the selected participants.
CSPC PHARMA (01093) announced that on June 25, 2026, the trustee purchased a total of 5.95 million shares of the company in the market in accordance with the terms and conditions of the 2026 Share Incentive Plan and held these shares in trust for the benefit of the selected participants.
In addition, as of the date of this announcement, the trustee of the 2018 Share Incentive Plan, Bank of China International UK PRU Trust Limited, held 117 million shares in trust in accordance with the terms and conditions of the plan.
Related Articles
Muyuan Foods Group (02714) plans to invest 300 million to 500 million Hong Kong dollars to repurchase H shares.
NEP Interlong is planning to acquire a portion of Jinbaihui's equity through the issuance of new shares or the acquisition of existing shares.
BAIWANG CO (06657) and Ant Blockchain Technology signed a "Strategic Cooperation Framework Agreement".
Muyuan Foods Group (02714) plans to invest 300 million to 500 million Hong Kong dollars to repurchase H shares.
NEP Interlong is planning to acquire a portion of Jinbaihui's equity through the issuance of new shares or the acquisition of existing shares.
BAIWANG CO (06657) and Ant Blockchain Technology signed a "Strategic Cooperation Framework Agreement".
RECOMMEND
